GHISELLI, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 6.019
EU - Europa 3.113
AS - Asia 2.508
SA - Sud America 579
AF - Africa 177
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.409
Nazione #
US - Stati Uniti d'America 5.923
SG - Singapore 1.129
UA - Ucraina 623
BR - Brasile 487
CN - Cina 467
IT - Italia 376
RU - Federazione Russa 359
SE - Svezia 345
DE - Germania 344
IE - Irlanda 329
TR - Turchia 272
DK - Danimarca 234
HK - Hong Kong 220
FI - Finlandia 184
VN - Vietnam 165
FR - Francia 125
KR - Corea 123
CI - Costa d'Avorio 113
GB - Regno Unito 100
CA - Canada 43
MX - Messico 38
AR - Argentina 37
IN - India 26
MA - Marocco 25
ZA - Sudafrica 24
BD - Bangladesh 20
EC - Ecuador 18
JP - Giappone 17
ID - Indonesia 16
PL - Polonia 16
BE - Belgio 15
IQ - Iraq 14
NL - Olanda 14
CO - Colombia 12
AT - Austria 11
ES - Italia 9
PY - Paraguay 8
RO - Romania 8
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
LT - Lituania 5
PE - Perù 5
DO - Repubblica Dominicana 4
EG - Egitto 4
EU - Europa 4
IL - Israele 4
OM - Oman 4
AL - Albania 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CR - Costa Rica 3
IR - Iran 3
SA - Arabia Saudita 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AO - Angola 2
AU - Australia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
HR - Croazia 2
KE - Kenya 2
KI - Kiribati 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
IS - Islanda 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
TO - Tonga 1
TW - Taiwan 1
WS - Samoa 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.409
Città #
Singapore 656
Jacksonville 623
Ashburn 592
Chandler 568
Fairfield 442
Dallas 391
Dublin 329
Boardman 293
Wilmington 246
Woodbridge 225
Hong Kong 214
New York 207
Seattle 189
Houston 169
Ann Arbor 139
Lawrence 131
Princeton 131
San Mateo 127
Beijing 122
Cambridge 119
Moscow 114
Abidjan 113
Hefei 81
Los Angeles 74
Des Moines 70
Munich 68
Ho Chi Minh City 66
Turin 63
Buffalo 55
San Diego 51
Centro 49
Turku 44
São Paulo 42
Hanoi 33
The Dalles 32
Guangzhou 22
London 22
Helsinki 21
Santa Clara 21
Chicago 20
Shanghai 20
Mexico City 18
Porto 17
Johannesburg 16
Rome 16
Brasília 15
Denver 15
Atlanta 14
Brussels 14
Montreal 14
Tokyo 14
Norwalk 13
Ottawa 13
Rio de Janeiro 13
Warsaw 13
Columbus 12
Izmir 12
Pune 12
Redmond 12
Belo Horizonte 11
Nuremberg 11
Wuhan 11
Ancona 10
Falls Church 10
Fermo 10
Kilburn 10
Washington 10
Brooklyn 9
Jakarta 9
Salt Lake City 9
Baghdad 8
Campinas 8
Dronten 8
Guayaquil 8
Poplar 8
Stockholm 8
Ankara 7
Haiphong 7
Phoenix 7
Biên Hòa 6
Boston 6
Chennai 6
Curitiba 6
Jiaxing 6
Manchester 6
Orem 6
San Francisco 6
Wuxi 6
Auburn Hills 5
Can Tho 5
Da Nang 5
Dhaka 5
Guarulhos 5
Joinville 5
Maceió 5
Marche 5
Porto Alegre 5
San Jose 5
Vienna 5
Aracaju 4
Totale 7.539
Nome #
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 296
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 233
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 204
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 176
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 175
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 164
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 153
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 144
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 142
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 132
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 131
Attività ed espressione della ossido-nitrico sintetasi nella vescica di ratti sottoposti a neuromodulazione sacrale 129
Anastomotic healing in a rat model of peritonitis after non-steroidal anti-inflammatory drug administration. 124
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 124
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 122
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 121
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 121
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 120
Functional outcomes after TEM in patients with complete clinical response after neoadjuvant chemoradiotherapy 119
Is the bipolar vessel sealer device an effective tool in robotic surgery? A retrospective analysis of our experience and a meta-analysis of the literature about different robotic procedures by investigating operative data and post-operative course 119
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 117
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 116
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 115
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 114
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 114
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 114
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 111
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 109
Effect of omiganan on colonic anastomosis healing in a rat model of peritonitis 109
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 108
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 108
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 107
The biocompatibility of dibutyryl chitin in the context of wound dressings. 106
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 106
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 106
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 104
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 104
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 103
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 103
Urinary catheters and biofilm formation 103
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 103
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 102
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 102
Minimally invasive approach to the adrenal gland in obese patients with Cushing’s syndrome 101
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 100
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 100
Increase of n-NOS and i-NOS in Rat Colon After Sacral Neuromodulation 100
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 99
Transanal endoscopic microsurgery as optimal option in treatment of rare rectal lesions: A single centre experience. 98
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 97
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 97
Association of Delayed Surgery With Oncologic Long-term Outcomes in Patients With Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation 96
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 95
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 95
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 95
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 95
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 95
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 95
S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis. 95
Transanal endoscopic microsurgery: indications, tips and long-term results. A single center experience 95
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 94
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 94
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 93
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 93
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 92
S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis. 92
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 91
Treatment of rectal cancer by transanal endoscopic microsurgery: experience with 425 patients. 91
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 89
Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. 88
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. 88
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 87
Effect of mono-dose intraperitoneal cecropins in experimental septic shock 87
LL-37 protects rats against lethal gram-negative sepsis. 86
Efficacy of LL-37 and Granulocyte-Colony Stimulating Factor in a Neutropenic Murine Sepsis due to Pseudomonas aeruginosa 85
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. 85
Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus. 85
Totally robotic vs 3D laparoscopic colectomy: A single centers preliminary experience 85
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. 84
Transanal endoscopic microsurgery in the treatment of large rectal adenomas. 84
Treatment of Staphylococcus aureus Biofilm infection by the quorum sensing inhibitor RIP 83
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 83
Nitric Oxide Synthase Expression in Rat Anorectal Tissue after Sacral Neuromodulation 82
Efficacy of cathelicidin ll-37 in an mrsa wound infection mouse model 82
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 81
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. 80
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 80
Robotic versus laparoscopic right colectomy for cancer: short-term outcomes and influence of Body Mass Index on conversion rate. 79
Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide 78
Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation 78
Set-up and statistical validation of a new scoring system for obstructed defaecation syndrome.Colorectal Dis. 2008 Jan;10(1):84-8 77
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 77
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 77
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 77
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection. 75
Laparoscopic repair of giant Morgagni hernia by direct suturing with V-Loc. 74
Functional outcomes after TEM in patients with complete clinical response after neoadjuvant chemoradiotherapy 74
Potential therapeutic role of cationic peptides in three experimental models of septic shock 72
The bovine antimicrobial peptide BMAP-28 reduces lethality due to bacterial cell wall components in mouse models of staphylococcal sepsis 72
Protective Effect of Citropin 1.1 and Tazobactam-Piperacillin Against Oxidative Damage and Lethality in Mice Models of Gram-Negative Sepsis. 72
Totale 10.507
Categoria #
all - tutte 62.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.007


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.083 0 0 0 0 0 131 203 120 191 170 198 70
2021/20221.034 73 228 10 52 22 71 45 51 65 125 86 206
2022/20231.767 182 197 138 134 128 211 3 100 443 13 159 59
2023/2024975 175 21 59 145 168 253 17 20 5 13 14 85
2024/20252.426 283 190 131 123 104 159 249 113 455 118 247 254
2025/20262.534 371 479 435 587 569 93 0 0 0 0 0 0
Totale 12.562